Diametric Capital’s Outset Medical OM Stock Holding History

Diametric Capital’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,242	Closed	-$1.26M	–	401
2022 Q4	$1.26M	Buy	+3,242	New	+$914K	0.6%	36

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EHI

Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return

Diametric Capital's OM Position: Q1 2023 in Review

Diametric Capital sold out of Outset Medical (OM) in Q1 2023, closing a stake of 3,242 shares — an estimated $1.26M sold.

Diametric Capital first reported a position in OM in Q4 2022 and held it in 1 quarter. The position peaked at $1.26M in Q4 2022. 162 funds tracked by Wall St. Rank hold OM as of Q1 2023.

Diametric Capital reported no remaining Outset Medical position as of Q1 2023 after selling out during the quarter.
Diametric Capital sold 3,242 Outset Medical shares in Q1 2023, an estimated $1.26M.
Diametric Capital first reported a position in Outset Medical in Q4 2022 and held it in 1 quarter.
Diametric Capital's Outset Medical position peaked at $1.26M in Q4 2022.
162 funds tracked by Wall St. Rank held Outset Medical as of Q1 2023.

Based on Diametric Capital's 13F filing for Q1 2023, filed 11 May 2023.